To Compare the Efficacy of Tamsulosin and Deflazacort Combination with Tamsulosin Alone in Expulsion of Lower Ureteric Stones in a Medical College in South Haryana
Introduction: Men have been suffering from urinary stones since antiquity. Symptomatic ureteric stone is a very common emergency condition faced by general surgeons and urologists. There are many medical and interventional treatments for lower ureteric stones. Removal of stone with ureteroscopy is very effective but this is very costly also. Anesthetist is required; stent is placed in ureter which has to be removed afterward. Stones of size <4 mm will pass hopefully spontaneously. Stones more than 10 mm size will require surgery in general. The expulsion of stones of size 4–10 mm can be tried with the help of pharmacological agents.
Materials and Methods: This prospective observational study was conducted in the Surgery Department at SGT Medical College located in South Haryana. A total of 150 patients of distal ureteric stones of sizes 4–10 mm were taken in this study, divided into two groups of 75 patients each. Group I patients were given tamsulosin 0.4 mg and deflazacort 30 mg once in a day and Group II patients were given tamsulosin 0.4 mg once in a day. Treatment was for 10 days.
Results: In Group I, the stones were expelled in 24 (32%) patients. While in Group II, 11 (14.6%) patients passed stones. This is statistically significant with P = 0.023. The median time for stone expulsion was 192 h in Group I and 312 h in Group II with again a significant P = 0.039.
Conclusion: We conclude that Group I (tamsulosin + deflazacort) showed a statistically significant advantage in stone expulsion rate than Group II (tamsulosin alone). Group I also showed a statistically significant advantage in stone expulsion time
management. In: Retik AB, Vaughan ED Jr., Wein AJ, Kavoissi LR,
Novick AC, Partin AW, editors. Cambell’s Urology. 8th ed. Philadelphia,
PA: Saunders; 2002. p. 3229-305.
2. Sachs M. The prohibition of lithotomy within the Hippocratic Oath:
Historical and ethical considerations on the history of surgery. Zentralbl
3. Pak CY. Kidney stones. Lancet 1998;351:1797-801.
4. Smith RD, Shah M, Patel A. Recent advances in management of ureteral
calculi. F1000 Med Rep 2009;1:53.
5. Zhang MY, Ding ST, Lü JJ, Lue YH, Zhang H, Xia QH. Comparison of
tamsulosin with extracorporeal shock wave lithotripsy in treating distal
ureteral stones. Chin Med J (Engl) 2009;122:798-801.
6. Bhat MS. SRB’s Manual of Surgery, 5th ed. New Delhi: Jaypee Brothers
Medical Publishers; 2016.
7. Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: A
guide for patient education. J Urol 1999;162:688-90.
8. Turk TM, Jenkins AD. A comparison of ureteroscopy to in situ
extracorporeal shock wave lithotripsy for the treatment of distal ureteral
calculi. J Urol 1999;161:45-6.
9. Eden CG, Mark IR, Gupta RR, Eastman J, Shrotri NC, Tiptaft RC.
Intracorporeal or extracorporeal lithotripsy for distal ureteral calculi? Effect
of stone size and multiplicity on success rates. J Endourol 1998;12:307-12.
10. Anderson KR, Keetch DW, Albala DM, Chandhoke PS, McClennan BL,
Clayman RV. Optimal therapy for the distal ureteral stone: Extracorporeal
shock wave lithotripsy versus ureteroscopy. J Urol 1994;152:62-5.
11. Peschel R, Janetschek G, Bartsch G. Extracorporeal shock wave lithotripsy
versus ureteroscopy for distal ureteral calculi: A prospective randomized
study. J Urol 1999;162:1909-12.
12. Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to
facilitate passage of ureteral calculi. Ann Emerg Med 2007;50:552-63.
13. Weiss RM, Bassett AL, Hoffman BF. Adrenergic innervation of the ureter.
Invest Urol 1978;16:123-7.
14. Sandegard E. The results of expectant treatment of ureterolithiasis:
Follow-up study of kidney function and recurrences. Acta Chir Scand
15. Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S, Palazzolo F, et al.
Evidence for the presence of alpha1 adrenoceptor subtypes in the human
ureter. Neurourol Urodyn 2005;24:142-8.
16. Morita T, Wada I, Saeki H, Tsuchida S, Weiss RM. Ureteral urine transport:
Changes in bolus volume, peristaltic frequency, intraluminal pressure and
volume of flow resulting from autonomic drugs. J Urol 1987;137:132-5.
17. Morita T, Wada I, Suzuki T, Tsuchida S. Characterization of
alpha-adrenoceptor subtypes involved in regulation of ureteral fluid
transport. Tohoku J Exp Med 1987;152:111-8.
18. Rajpathy J, Aswathaman K, Sinha M, Subramani S, Gopalakrishnan G,
Kekre NS. An in vitro study on human ureteric smooth muscle with the
alpha1-adrenoceptor subtype blocker, tamsulosin. BJU Int 2008;102:1743‑5.
19. Tripathi KD. Antiadrnergic drugs (adrenergic receptor antagonist). In:
Essential of Medical Pharmacology. 5th ed. New Delhi: Jaypee Brothers
Medical Publisher Pvt. Ltd.; 2003. p. 119-31.
20. Yamaguchi K, Minei S, Yamazaki T, Kaya H, Okada K. Characterization of
ureteral lesions associated with impacted stones. Int J Urol 1999;6:281-5.
21. Porpiglia F, Vaccino D, Billia M, Renard J, Cracco C, Ghignone G,
et al. Corticosteroids and tamsulosin in the medical expulsive therapy for
symptomatic distal ureter stones: Single drug or association? Eur Urol
22. Dellabella M, Milanese G, Muzzonigro G. Medical-expulsive therapy
for distal ureterolithiasis: Randomized prospective study on role of
corticosteroids used in combination with tamsulosin-simplified treatment
regimen and health-related quality of life. Urology 2005;66:712-5.
23. Borghi L, Meschi T, Amato F, Novarini A, Giannini A, Quarantelli C,
et al. Nifedipine and methylprednisolone in facilitating ureteral stone
passage: A randomized, double-blind, placebo-controlled study. J Urol
24. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy
of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy
for distal ureteral calculi. J Urol 2005;174:167-72.
25. Porpiglia F, Ghignone G, Fiori C, Fontana D, Scarpa RM. Nifedipine
versus tamsulosin for the management of lower ureteral stones. J Urol
26. Cervenàkov I, Fillo J, Mardiak J, Kopecný M, Smirala J, Lepies P. Speedy
elimination of ureterolithiasis in lower part of ureters with the alpha
1-blocker tamsulosin. Int Urol Nephrol 2002;34:25-9.
27. Autorino R, De Sio M, Damiano R, Di Lorenzo G, Perdonà S, Russo A,
et al. The use of tamsulosin in the medical treatment of ureteral calculi:
Where do we stand? Urol Res 2005;33:460-4.
28. Kaneko T, Matsushima H, Morimoto H, Tsuzaka Y, Homma Y. Efficacy
of low dose tamsulosin in medical expulsive therapy for ureteral stones
in Japanese male patients: A randomized controlled study. Int J Urol
29. Griwan MS, Singh SK, Paul H, Pawar DS, Verma M. The efficacy of
tamsulosin in lower ureteral calculi. Urol Ann 2010;2:63-6.